4//SEC Filing
Mallon Mark 4
Accession 0001077183-21-000278
CIK 0001077183other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 6:05 PM ET
Size
6.2 KB
Accession
0001077183-21-000278
Insider Transaction Report
Form 4
Mallon Mark
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-12-30+152,858→ 225,594 total
Holdings
- 151,016
Stock Option (Right to Buy)
Exercise: $49.34Exp: 2028-04-19→ Common Stock (151,016 underlying)
Footnotes (2)
- [F1]On December 30, 2021, Mr. Mallon was granted 152,858 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
- [F2]On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001763533
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 6:05 PM ET
- Size
- 6.2 KB